Skip to Main Content

Paper Details

Excellent Response to Fam-Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma With CNS Metastasis: A Case Report.
JCO Precision Oncology
1
2022
CNS Metastasis, Fam, Human, Human Epidermal Growth Factor Receptor 2, Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma, Trastuzumab
Author NameAffiliation
Maie A St JohnDavid Geffen School of Medicine, University of California los angeles
  • 1 - 1

Datasets

Release 1.2